Clinical Trial Update: Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena. [NA]

View source ↗

Summary

A terminated clinical trial evaluating non-invasive vagus nerve stimulation using gammaCore for Raynaud's phenomenon has posted results, indicating potential be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Drugs mentioned

• gammaCore

Snippet

Sponsor: University of Toledo Health Science Campus | Conditions: Raynaud Phenomenon, Primary Raynaud Phenomenon | NA | Status: TERMINATED | Results posted: 2025-07-15